Using a risk prediction tool, mortality of lung cancer patients can be reduced. But, risk-based screening is less efficient in terms of life-years saved, quality-adjusted life-years (QALYs), and cost-effectiveness, reveals a new study.
Most current lung cancers screening guidelines, including those from the U.S. Preventive Services Task Force (USPSTF), use screening criteria based on findings from the National Lung Screening Trial. The findings are published in iAnnals of Internal Medicine....
↧